What's in MacroGenics, Inc.'s pipeline?

MacroGenics, Inc. has 13 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 11 in Phase 1.

Which companies overlap with MacroGenics, Inc.'s portfolio?

Top competitors by shared drug class: Beijing Chaoyang District Centre for Disease Control and Prevention, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, China, Federal University of Espirito Santo, International Vaccine Institute.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/macrogenics.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

MacroGenics, Inc. — Portfolio Competitive Intelligence Brief

MacroGenics, Inc. (MGNX) pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

MGNX (NASDAQ) 1 marketed 0 filed 1 Phase 3 0 Phase 2 11 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Hepatitis A vaccine	Hepatitis A vaccine	marketed	inactivated viral vaccine	Hepatitis A virus surface antigens	Immunology
Physician's choice of chemotherapy.	Physician's choice of chemotherapy.	phase 3			Oncology

Therapeutic area mix

Immunology · 1
Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beijing Chaoyang District Centre for Disease Control and Prevention · 1 shared drug class
Centers for Disease Control and Prevention · 1 shared drug class
Centers for Disease Control and Prevention, China · 1 shared drug class
Federal University of Espirito Santo · 1 shared drug class
International Vaccine Institute · 1 shared drug class
Sanofi Pasteur, a Sanofi Company · 1 shared drug class
Shandong Province Centers for Disease Control and Prevention · 1 shared drug class
Sinovac Biotech Co., Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for MacroGenics, Inc.:

Cite this brief

Drug Landscape (2026). MacroGenics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/macrogenics. Accessed 2026-05-13.